Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03337750 · ClinicalTrials.gov registry record · NA

An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military

A NA study of Post Traumatic Stress Disorder and Combat Disorders, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
34
Enrollment target
2
Study locations

NCT03337750: Completed NA study of Post Traumatic Stress Disorder and Combat Disorders, sponsored by University of Pennsylvania.

NCT03337750 is a NA study of Post Traumatic Stress Disorder and Combat Disorders that has completed, run by University of Pennsylvania. The registered enrollment target is 34 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03337750, a NA study of Post Traumatic Stress Disorder and Combat Disorders, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
2
Study locations

Study Summary

It is urgent to make evidence-based treatments (EBTs) for military personnel readily accessible in order to meet the growing demand for effective and efficient treatment for posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are available, but barriers to accessing care can deter military personnel from receiving treatment. Web-treatments represent an innovative way to overcome these barriers. The efficacy of previously developed web-treatments for PTSD appear promising, however, they are not based on treatment protocols with strong empirical support for their efficacy. No study to date has examined web-treatment of PTSD using a well-established treatment program. The purpose of this open trial is to examine the efficacy of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks in 40 active-duty military personnel and veterans with PTSD who deployed post 9-11. Up to 60 individuals will be consented to obtain data from 40 for analysis. Participants will be assessed at pre-treatment and 1- and 3-months after treatment completion.

Primary Outcome

A 20-item self-report measure of PTSD symptoms as defined by the DSM-5. Higher scores indicate greater PTSD symptom severity.

Interventions

  • BEHAVIORAL Web-PE Therapy

Study Locations (2)

Pennsylvania

  • Center for the Treatment and Study of Anxiety, University of Pennsylvania - Philadelphia

Texas

  • University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2018-02-12
Est. Completion 2020-02-14
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT03337750 record still lists

NCT03337750 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Web-PE Therapy is the first listed.

NCT03337750 reports a single indexed study location in Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT03337750 about?

NCT03337750 is a clinical study titled "An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military". It is urgent to make evidence-based treatments (EBTs) for military personnel readily accessible in order to meet the growing demand for effective and efficient treatment for posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are available, but barriers to accessing care...

What is the current status of trial NCT03337750?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2018-02-12. Estimated completion is 2020-02-14.

What conditions does trial NCT03337750 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Combat Disorders.

What interventions are being tested in trial NCT03337750?

The interventions under investigation include: Web-PE Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03337750?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03337750 being conducted?

This trial has 2 study locations across Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03337750's enrollment target sits among peer trials

34 202nd of 262 higher than 60 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03337750, the US trial registry maintained by the National Library of Medicine. NCT03337750 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.